Navigation Links
Precision Economy Incubators 5EG

ProductsPrecision Economy Incubators 5EG
Company Precision Medical, Inc.
Item Precision Economy Incubators 5EG
Features Broad temperature range, excellent temperature control. Small footprint, large capacity. Simple to maintain. UL listed.
Description Precision Economy Incubators available in five different models. Choose mechanical or gravity convection; capacities of 1.4 cu. Ft. (39 liters), 2.5 cu. Ft. (71.5 liters), or 4.5 cu. ft. (129 liters. Equally important, Precision Economy Incubators combine a wide temperature range with excellent temperature sensitivity, stability, and uniformity. As a result, you will find them ideal for a broad range of applications. It is also designed to help you conserve precious bench space, packing up to 11.5 sq. ft. (1.0 sq. m.). Plus they come equipped with a standard cord so you can have them up and operating in your lab in just minutes.
Info Precision Medical, Inc.
Customer Service: (800) 272-7285
Web site: http://www.precisionmedical.com

Related medicine products :

1. Precisionist Phacoemulsification System
2. Precision Programmable Autoclaves
3. Precision Economy Incubators 3EM
4. Precision Economy Incubators 5EM
5. Precision Economy Incubators 2EG
6. Precision Economy Incubators 3EG
7. Pocket II Precision Pachymeter
8. Precision Xtra Advanced Diabetes Tester
9. Precision Net
10. Precision PCx® Point-of-Care System
11. Precision Hand Instrumentation: 3.4mm Low Profile
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10BioCryst Provides Update Regarding Peramivir for Influenza 5116 1BioCryst Provides Update Regarding Peramivir for Influenza 5116 2BioCryst Provides Update Regarding Peramivir for Influenza 5116 3BioCryst Provides Update Regarding Peramivir for Influenza 5116 4BioCryst Provides Update Regarding Peramivir for Influenza 5116 5Study explores how life experiences contribute to the biological changes of Alzheimers 10197 1Study explores how life experiences contribute to the biological changes of Alzheimers 10197 2Study explores how life experiences contribute to the biological changes of Alzheimers 10197 3Doctor Visits Are Getting Short Shrift in Tight Economy 58589 1Doctor Visits Are Getting Short Shrift in Tight Economy 58589 2